[1] McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium[J]. Neurology,2005,65(12):1863-1872. [2] McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium[J]. Neurology,2017,89(1):88-100. [3] Hogan DB, Fiest KM, Roberts JI, et al. The Prevalence and Incidence of Dementia with Lewy Bodies: a Systema-tic Review[J]. Can J Neurol Sci,2016,43 Suppl 1:S83-S95. [4] Jellinger KA.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies[J]. J Neural Transm(Vienna),2018,125(4):615-650. [5] Haider A, Dulebohn SC.Dementia, Lewy body[M]. Treasure Island (FL): StatPearls Publishing,2018. [6] Kim WS, Kågedal K, Halliday GM.Alpha-synuclein biology in Lewy body diseases[J]. Alzheimers Res Ther,2014, 6(5):73. [7] Ferman TJ, Boeve BF, Smith GE, et al.Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies[J]. Neurology,2011,77(9):875-882. [8] Connors MH, Quinto L, McKeith I, et al. Non-pharmacological interventions for Lewy body dementia: a systema-tic review[J]. Psychol Med,2018,48(11):1749-1758. |